Cargando…
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
With the intent of dissecting the molecular complexity of Philadelphia-negative myeloproliferative neoplasms (MPN), we designed a target enrichment panel to explore, using next-generation sequencing (NGS), the mutational status of an extensive list of 2000 cancer-associated genes and microRNAs. The...
Autores principales: | Tenedini, E, Bernardis, I, Artusi, V, Artuso, L, Roncaglia, E, Guglielmelli, P, Pieri, L, Bogani, C, Biamonte, F, Rotunno, G, Mannarelli, C, Bianchi, E, Pancrazzi, A, Fanelli, T, Malagoli Tagliazucchi, G, Ferrari, S, Manfredini, R, Vannucchi, A M, Tagliafico, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017260/ https://www.ncbi.nlm.nih.gov/pubmed/24150215 http://dx.doi.org/10.1038/leu.2013.302 |
Ejemplares similares
-
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
por: Vannucchi, A M, et al.
Publicado: (2014) -
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
por: Vannucchi, Alessandro M, et al.
Publicado: (2009) -
Chronic Myeloproliferative Neoplasms: a Collaborative Approach
por: Pieri, Lisa, et al.
Publicado: (2010) -
Recent advances in diagnosis and treatment of chronic myeloproliferative neoplasms
por: Guglielmelli, Paola, et al.
Publicado: (2010) -
mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms
por: Bogani, Costanza, et al.
Publicado: (2013)